- Conditions
- Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma, Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma, +85 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Clinical trial condition
Refractory Childhood Malignant Germ Cell Tumor
Explore clinical trials studying Refractory Childhood Malignant Germ Cell Tumor. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Refractory Childhood Malignant Germ Cell Tumor trial results
Active, Not Recruiting
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
NCT03210714
- Conditions
- Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +74 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
Related conditions
- Advanced Malignant Solid Neoplasm (2)
- Central Nervous System Neoplasms (2)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)
- Ependymoma (2)
- Familial ependymoma (2)
- Female Urogenital Diseases (2)
- Female Urogenital Diseases and Pregnancy Complications (2)
- Genetic Diseases, Inborn (2)